121.
|
anti-TNF (tumour necrosis factor) therapy [farm.] [ch. uk³.ruchu] trafno¶æ: 6.6pkt.zaloguj siê |
122.
|
Malignant tumour, fusiform cell type
³ac.Neoplasma malignum fusocellulare[onk.] [cyt/hist] trafno¶æ: 6.6pkt.zaloguj siê |
123.
|
calcifying epithelial odontogenic tumour {CEOT}, {CE-OT} [med.] [stom/prot] [onk.] trafno¶æ: 6.6pkt.zaloguj siê |
124.
|
supratentorial primitive neuroectodermal tumour {sPNET} [med.] [onk.] trafno¶æ: 6.6pkt.zaloguj siê |
125.
|
circulating tumour cells of solid tumours [med.] [onk.] trafno¶æ: 6.6pkt.zaloguj siê |
126.
|
Placental site trophoblastic tumour {PSTT} [onk.] [ginek./po³] trafno¶æ: 6.6pkt.zaloguj siê |
127.
|
cellular mechanisms affecting tumour cell proliferation [med.] [onk.] [cyt/hist] trafno¶æ: 6.5pkt.zaloguj siê |
128.
|
Malignant lymphoma, mixed small cleaved and large cells, follicular [med.] [onk.] trafno¶æ: 6.5pkt.zaloguj siê |
129.
|
Follicular (nodular) non-Hodgkin's lymphoma - Mixed small cleaved and large cell, follicular [med.] [onk.] trafno¶æ: 6.0pkt.zaloguj siê |
130.
|
mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side [med.] [otolaryng] trafno¶æ: 6.0pkt.zaloguj siê |
* Dok³adamy wszelkich starañ, aby wprowadzane przez nas has³a by³y poprawne. Jednak mimo weryfikacji, mog± pojawiæ siê b³êdy, za które wydawca nie bierze odpowiedzialno¶ci. Ka¿dy u¿ytkownik wykorzystuje has³a zawarte w s³owniku Verba Medica na w³asn± odpowiedzialno¶æ.